A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

NCT07533565 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Asthma

Interventions

DRUG: Mirabegron 100 mg
DRUG: Mirabegron 50mg
DRUG: Mirabegron 50mg
DRUG: mirabegron 25 mg
DRUG: Montelukast 10 mg
DRUG: montelukast (5mg QD)
DRUG: montelukast 4 mg granule

Sponsor

Kafrelsheikh University